GLP-1 treatment prescribed, dosed, and monitored by a board-certified physician — not a questionnaire.
Most online weight programs are built for volume. Nuurin is built the way medicine should be practiced.
Every treatment decision at Nuurin is made by a board-certified physician who reviews your history, meets you, and follows your care — not an automated intake form.
GLP-1 medications are not one-size-fits-all. Your dose is chosen and adjusted based on your response, your labs, and your goals — at a pace that's right for your body.
Weight care is ongoing medicine. Regular check-ins, lab work when indicated, and a physician who knows your chart — from your first visit onward.
From first questionnaire to ongoing care, designed to be simple for you and rigorous behind the scenes.
Complete a detailed medical intake from home. Your information goes directly to a physician — not a screening algorithm.
A video visit with a board-certified doctor to review your history, discuss your goals, and determine whether treatment is right for you.
If treatment is clinically appropriate, your physician prescribes and your medication ships from a licensed pharmacy.
Scheduled follow-ups, dose adjustments, and lab monitoring when indicated. Message your care team anytime.
GLP-1 receptor agonist medications — including tirzepatide, when clinically appropriate — work with your body's own hormonal signals that regulate appetite and blood sugar.
They are powerful tools. And like all prescription medications, they carry risks and side effects, work differently for different people, and are not appropriate for everyone. That's exactly why treatment should be led by a physician.
No before-and-after photos. No promises. Here's what a typical year of physician-led treatment actually involves — drag through it.
This timeline is illustrative of a typical care journey. Your plan may look different — every dose, visit, and decision is individualized by your physician, and treatment is only initiated when clinically appropriate.
Nuurin was founded by a nephrologist — a physician who has spent his career treating what untreated metabolic disease leads to: kidney disease, hypertension, and diabetes.
After years of meeting patients downstream, he decided to move upstream — to build the kind of weight care he'd want for his own patients: personal, evidence-based, and led by a doctor from the first visit to every visit after.
Weight care today is full of noise, shortcuts, and one-size-fits-all programs. Nuurin exists to bring clarity to it.
Full pricing will be announced at launch. Here's what membership will include.
We're in the final stages of building Nuurin and expect to welcome our first patients soon. Waitlist members will be the first to know — and first in line.
Eligibility is determined by a physician after reviewing your health history and meeting with you. GLP-1 treatment is generally considered for adults who meet clinical criteria for medical weight management, but every decision at Nuurin is individualized.
We'll announce availability at launch. Telehealth rules vary by state, and we'll only practice where we're fully licensed to care for you.
Nuurin will offer GLP-1 receptor agonist medications, including tirzepatide, when a physician determines treatment is clinically appropriate. Medication options will be discussed during your consultation.
The short answer: a physician. Nuurin was founded by a board-certified physician, and every patient is evaluated, prescribed for, and followed by a board-certified doctor — with individualized dosing, lab monitoring when indicated, and ongoing follow-up rather than a one-time approval.
Medication costs are separate from membership and always shown clearly before you commit. We'll publish full pricing details at launch.
GLP-1 medications are FDA-regulated prescription treatments with established benefits and known risks and side effects. They aren't right for everyone — which is why Nuurin requires a physician evaluation before any prescription, and monitors every patient throughout treatment. Your doctor will review complete safety information with you.
Join the waitlist for early access, launch pricing, and updates from our founding physician.